Darolutamide – May 2023

• Brand names:
  • Nubeqa®
• Pharmaceutical Company:
  • Bayer Australia Ltd
• Condition/Indication: Prostate cancer
• Meeting Date: May 2023
• Public Summary Document (PSD) November 2022 May 2023 PBAC Meetings – (PDF 1.5MB)
• Public Summary Document (PSD) November 2022 May 2023 PBAC Meetings – (Word 1.5MB)

Related Public Summary Documents

• Darolutamide - November 2022